Nov 8 (Reuters) - Novo Nordisk (NOVOb.CO), opens ... "Novo Nordisk will phase out, then permanently discontinue Levemir in the U.S. on December 31, 2024," the company said in a statement.

is discontinuing Levemir in the United States due to “global manufacturing issues, decreasing patient coverage, and because we are confident that patients in the U.S. will be able to find ...